Pharmacological safety during pregnancy: the principles of teratogenesis and teratogenicity of drugs

Drugs used during pregnancy simultaneously have an impact on 2 populations — fetal and maternal. The article is devoted to teratogenic drugs exposition; it points out the need for further research in the field of pharmaceutical safety during pregnancy. Authors analyzed the multiplicity of the congen...

Full description

Saved in:
Bibliographic Details
Main Authors: O. V. Reshet’ko, K. A. Lutsevich, N. I. Klimenchenko
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2016-06-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/1399
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Drugs used during pregnancy simultaneously have an impact on 2 populations — fetal and maternal. The article is devoted to teratogenic drugs exposition; it points out the need for further research in the field of pharmaceutical safety during pregnancy. Authors analyzed the multiplicity of the congenital disorders in infants, including birth defects cuased by drug application. For ethical reasons, researchers can not conduct any studies on the safety of medicines during pregnancy. Authors suppose that collection of additional information during the marketing phase as a part of the routine pharmacovigilance program and the targeted pharmacoepidemiological trials with the current evaluation of the teratogenic risk of drugs will help to achieve the goals.
ISSN:1727-5776
2500-3089